SMITHFIELD, R.I., July 17, 2012 /PRNewswire-iReach/ -- Smithfield, RI-July 17, 2012 EquinoxO2 Medical, LLC, developer of negative pressure wound therapy (NPWT) foam dressings and pump systems, announced today development and distribution of its HALO XP npwt pump system, Part# HXP2000. The HALO XP was designed for ambulatory patients. It's a light weight and portable system that combines advanced technology with easy-to-use features. The new portable npwt pump was created to provide an affordable option to patients and healthcare facilities.
Chronic, non healing or untreated wounds are clinically affecting many patients and adding significant cost to our healthcare system. This cost is estimated at $113 billion. This medical cost will continue to increase even with competitive bidding starting by the end of 2012. Equinox believes that affordable npwt technology should be available to all chronic patients. "We are very proud to offer patients and clinicians the HALO XP Pump System, the latest offering in our expanding npwt product portfolio for the successful treatment of all chronic wounds and affordable access to negative pressure therapy." said Rian Mallari, president and chief executive officer, EquinoxO2 Medical, LLC.
About EquinoxO2 Medical, LLC
Equinoxo2 Medical, LLC, headquartered in Smithfield, RI is a privately held medical device company focused on the development of advanced wound healing technology. Equinox is dedicated to developing and designing innovative wound care products that are cost effective and deliver significant clinical outcomes. Our goal and strategy is to improve a patient's quality of life. Our passion and dedication is to provide a better solution in repairing and healing the human body. For more information, please visit www.equinoxo2.com.
800-504-3150 Ext 3
Media Contact: Rian Mallari EquinoxO2 Medical, LLC, 800-504-3150 Ext 1, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE EquinoxO2 Medical, LLC|
Copyright©2012 PR Newswire.
All rights reserved